Human medicines European public assessment report (EPAR): Xenpozyme, olipudase alfa, Date of authorisation: 24/06/2022, Revision: 7, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 30 June 2025 - 6:20

Human medicines European public assessment report (EPAR): Xenpozyme, olipudase alfa, Date of authorisation: 24/06/2022, Revision: 7, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/xenpozyme

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters